Amanda Vrselja

Amanda Vrselja is a highly experienced professional in the fields of clinical science and research. Currently serving as Program Head and formerly as Analyst for CUREator at Brandon Capital since November 2021, Amanda has a strong background in oncology and clinical development, demonstrated through various roles at QUE Oncology from October 2018 to October 2021, including Clinical Scientist and Clinical Development Associate. Amanda's academic qualifications include a PhD in Cardiovascular and Renal Developmental Programming from Monash University, obtained from 2015 to 2019, along with a Bachelor of Science (Honours) specializing in Anatomy and Developmental Biology in 2012 and a Bachelor of Science focusing on Developmental Biology, Genetics, and Molecular Biology from 2008 to 2011. Additionally, Amanda contributed to Monash University as a Teaching Associate from July 2012 to June 2019.